BR9306138A - Peptídeos antivirais - Google Patents

Peptídeos antivirais

Info

Publication number
BR9306138A
BR9306138A BR9306138A BR9306138A BR9306138A BR 9306138 A BR9306138 A BR 9306138A BR 9306138 A BR9306138 A BR 9306138A BR 9306138 A BR9306138 A BR 9306138A BR 9306138 A BR9306138 A BR 9306138A
Authority
BR
Brazil
Prior art keywords
antiviral peptides
antiviral
peptides
Prior art date
Application number
BR9306138A
Other languages
English (en)
Inventor
Stephen Derek Albert Dr Street
Peter John Dr Whittle
Colin William Dr Greengrass
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB929206462A external-priority patent/GB9206462D0/en
Priority claimed from GB939301638A external-priority patent/GB9301638D0/en
Application filed by Pfizer filed Critical Pfizer
Publication of BR9306138A publication Critical patent/BR9306138A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Plural Heterocyclic Compounds (AREA)
BR9306138A 1992-03-25 1993-03-13 Peptídeos antivirais BR9306138A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929206462A GB9206462D0 (en) 1992-03-25 1992-03-25 Antiviral peptides
GB939301638A GB9301638D0 (en) 1993-01-27 1993-01-27 Antiviral peptides
PCT/EP1993/000597 WO1993019059A1 (en) 1992-03-25 1993-03-13 Antiviral peptides

Publications (1)

Publication Number Publication Date
BR9306138A true BR9306138A (pt) 1998-06-23

Family

ID=26300586

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9306138A BR9306138A (pt) 1992-03-25 1993-03-13 Peptídeos antivirais

Country Status (13)

Country Link
EP (1) EP0632808A1 (pt)
JP (1) JPH07501556A (pt)
KR (1) KR950700901A (pt)
AU (1) AU3748393A (pt)
BR (1) BR9306138A (pt)
CA (1) CA2131154A1 (pt)
CZ (1) CZ229594A3 (pt)
FI (1) FI944428A0 (pt)
HU (1) HU9402744D0 (pt)
NO (1) NO943540L (pt)
RU (1) RU94041225A (pt)
SK (1) SK114094A3 (pt)
WO (1) WO1993019059A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0565631B1 (en) * 1991-01-02 1996-09-18 Merrell Pharmaceuticals Inc. Anti-viral compounds
AU680009B2 (en) * 1993-07-08 1997-07-17 Aventisub Ii Inc. Difluoro statone analogs
KR100308839B1 (ko) * 1993-09-09 2002-10-04 메렐 파마슈티칼스 인크. 디플루오로 스타톤 항바이러스성 유사체
US6114380A (en) * 1995-12-18 2000-09-05 Merrell Pharmaceuticals Inc. Difluoro statone analogs
GB9601680D0 (en) 1996-01-27 1996-03-27 Pfizer Ltd Therapeutic agents
CN1158277C (zh) * 1998-02-02 2004-07-21 Lg化学株式会社 具有哌啶结构的法尼转移酶抑制剂及其制备方法
US6809200B2 (en) 2000-07-28 2004-10-26 Pfizer Inc. Process for the preparation of pyrazolo[4,3-d]pyrimidin-7-one compounds and intermediates thereof
WO2006108489A1 (en) 2005-04-14 2006-10-19 F. Hoffmann-La Roche Ag Aminopyrazole derivatives, their manufacture and use as pharmaceutical agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL91780A (en) * 1988-10-04 1995-08-31 Abbott Lab History of the amine of the xenon-preventing xanine acid, the process for their preparation and the pharmaceutical preparations containing them
IL92011A0 (en) * 1988-10-19 1990-07-12 Abbott Lab Heterocyclic peptide renin inhibitors
CA2010531A1 (en) * 1989-03-06 1990-09-06 Werner Neidhart Amino acid derivatives
KR920700221A (ko) * 1989-04-18 1992-02-19 원본미기재 극성 n-말단기들을 갖는 신규 리닌 억제인자 펩티드
DE4001236A1 (de) * 1990-01-18 1991-07-25 Bayer Ag Neue peptide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel, insbesondere als arzneimittel gegen retroviren

Also Published As

Publication number Publication date
FI944428A (fi) 1994-09-23
JPH07501556A (ja) 1995-02-16
WO1993019059A1 (en) 1993-09-30
NO943540D0 (no) 1994-09-23
FI944428A0 (fi) 1994-09-23
AU3748393A (en) 1993-10-21
NO943540L (no) 1994-11-21
CA2131154A1 (en) 1993-09-30
RU94041225A (ru) 1996-07-20
HU9402744D0 (en) 1994-12-28
CZ229594A3 (en) 1995-04-12
SK114094A3 (en) 1995-04-12
KR950700901A (ko) 1995-02-20
EP0632808A1 (en) 1995-01-11

Similar Documents

Publication Publication Date Title
NO942066L (no) Peptidderivater
DE69315842D1 (de) Peptidverbindungen
DE69325333D1 (de) Antivirale Zusammensetzung
ITMI931471A1 (it) Sci
NO307145B1 (no) Vindkraftverk
ATA255692A (de) Sportschuh
FI940109A0 (fi) Peptidejä
FI953127A0 (fi) Puriinijohdannaisia
ATA236892A (de) Rotornut
FI944428A (fi) Viruksen vastaisia peptidejä
GB9210744D0 (en) Antiviral peptides
NO932237D0 (no) Lineaere peptider
LV10286A (lv) Peptidu savienojumi
ATA227792A (de) Sportschuh
LV10287A (lv) Peptidu savienojumi
GB9206462D0 (en) Antiviral peptides
KR940018006U (ko) 전주용 완금
KR940000399U (ko) 납골단지
ITMI922963A0 (it) Peptidi ciclici
ITFE920014V0 (it) Endolancet b
BR7201859U (pt) Cambao
BR7202026U (pt) Aero-mala
ATA58493A (de) Lochstein
BR7200188U (pt) Hidro-cinzeiro
BR7200229U (pt) Doca-dupla

Legal Events

Date Code Title Description
FA7 Application withdrawn (art. 18 par. 1 of law 5772/71) - being contrary to morals, good customs and public security, order and health